Search research articles
Contact Us
Filters
Showing results (1191-1200 of 1,297) with videos related to
Page
of 130
Sort By:
Ebiomedicine
|
March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
Johannes Dorst, Patrick Weydt, David Brenner, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 3, 2001
In vitro human tissue models in risk assessment: report of a consensus-building workshop
J T MacGregor, J M Collins, Y Sugiyama, et al.
European Journal of Neurology
|
March 12, 2024
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)
Philip Van Damme, Ammar Al-Chalabi, Peter M Andersen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 23, 2015
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Petra Steinacker, Emily Feneberg, Jochen Weishaupt, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 3, 2021
COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study
Jing Sun, Rena C Patel, Qulu Zheng, et al.
Science Advances
|
June 22, 2019
Sortilin gates neurotensin and BDNF signaling to control peripheral neuropathic pain
Mette Richner, Lone T Pallesen, Maj Ulrichsen, et al.
Journal of Neurology
|
May 6, 2018
Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications
Peter M Andersen, Magdalena Kuzma-Kozakiewicz, Jürgen Keller, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Human Molecular Genetics
|
January 10, 2018
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency
Sarah J Brockmann, Axel Freischmidt, Patrick Oeckl, et al.
Page
of 130
Search research articles
Search
Showing results (1191-1200 of 1,297) with videos related to
Sort By:
Page
of 130
Ebiomedicine
|
March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
Johannes Dorst, Patrick Weydt, David Brenner, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 3, 2001
In vitro human tissue models in risk assessment: report of a consensus-building workshop
J T MacGregor, J M Collins, Y Sugiyama, et al.
European Journal of Neurology
|
March 12, 2024
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)
Philip Van Damme, Ammar Al-Chalabi, Peter M Andersen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 23, 2015
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Petra Steinacker, Emily Feneberg, Jochen Weishaupt, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 3, 2021
COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study
Jing Sun, Rena C Patel, Qulu Zheng, et al.
Science Advances
|
June 22, 2019
Sortilin gates neurotensin and BDNF signaling to control peripheral neuropathic pain
Mette Richner, Lone T Pallesen, Maj Ulrichsen, et al.
Journal of Neurology
|
May 6, 2018
Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications
Peter M Andersen, Magdalena Kuzma-Kozakiewicz, Jürgen Keller, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Human Molecular Genetics
|
January 10, 2018
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency
Sarah J Brockmann, Axel Freischmidt, Patrick Oeckl, et al.
Page
of 130